Published: Mar 12, 2021 | Tags: PhaseBio, Signs, Supply, Agreement, BioVectra, Support, Development, Commercialization, Bentracimab
Published: Mar 12, 2021 | Tags: Takeda, Reports, NDA, Submission, Lanadelumab, MHLW, Preventive, Treatment, Hereditary Angioedema Attack, Japan
Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19
Published: Mar 12, 2021 | Tags: Sanofi and Translate Bio, Initiate, P-I/II, Study, MRT5500, Against, COVID-19
Abbott Launches Pandemic Defense Coalition to Detect Future Threats
Published: Mar 12, 2021 | Tags: Abbott, Launches, Pandemic Defense Coalition, Detect, Future, Threats
Published: Mar 12, 2021 | Tags: Astellas, Reports, NDA, Submission, Enfortumab Vedotin, MHLW, Locally, Advanced, Metastatic, Urothelial Cancer, Japan
Vir and GSK Report Results of VIR-7831 in P-III COMET-ICE Trial for COVID-19
Published: Mar 12, 2021 | Tags: Vir and GSK, Report, Results, VIR-7831, P-III COMET-ICE, Trial, COVID-19
Vertex’s VX-880 Receives the US FDA’s Fast Track Designation for T1D
Published: Mar 11, 2021 | Tags: Vertex, VX-880, Receives, US, FDA, Fast Track Designation, T1D
Lannett Receives the US FDA’s Feedback for Development of Biosimilar Insulin Glargine
Published: Mar 11, 2021 | Tags: Lannett, Receives, US, FDA, Feedback, Development, Biosimilar Insulin Glargine
Published: Mar 11, 2021 | Tags: Roche, Actemra/RoActemra (tocilizumab), Veklury, Fail, Meet, Primary Endpoints, P-III REMDACTA, Study, Patients, Severe, COVID-19, Pneumonia
Published: Mar 11, 2021 | Tags: Empatica, Aura System, Receives, European, CE Mark, Detecting, Early Symptoms, COVID-19, Wearables
Grifols Acquires Remaining 56% of GigaGen for ~$80M
Published: Mar 11, 2021 | Tags: Grifols, Acquires, Remaining, 56%, GigaGen, ~$80M
Published: Mar 11, 2021 | Tags: Elli Lilly, Reports, Results, Bamlanivimab, Etesevimab, P-III BLAZE-1, Study, Prevention, COVID-19
Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI
Published: Mar 10, 2021 | Tags: Gilead, Present, Results, Lenacapavir, P-II/III CAPELLA, Trial, Treatment, HIV, CROI
SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine
Published: Mar 10, 2021 | Tags: SMA Foundation, Collaborates, PTC, Discover, Develop, Regenerative Medicine
Published: Mar 10, 2021 | Tags: Sorrento, Collaborates, Mount Sinai, Develop, Ab, Combination, Neutralizing, SARS-CoV-2, Emerging Variants, COVID-19
Published: Mar 10, 2021 | Tags: ViiV Healthcare, Presents, Results, GSK3640254 (GSK’254), P-IIa study, Treatment, HIV, CROI
Novartis’ Canakinumab Fails to Meet its Primary Endpoint in P-III CANOPY-2 Study
Published: Mar 10, 2021 | Tags: Novartis, Canakinumab, Fails, Meet, Primary Endpoint, P-III CANOPY-2, Study
Takeda to Acquire Maverick for ~$525M
Published: Mar 10, 2021 | Tags: Takeda, Acquire, Maverick, ~$525M
Published: Mar 9, 2021 | Tags: Exelixis, Signs, Exclusive, License, Agreement, WuXi Biologics, Expand, Growing, Oncology, Biologics, Pipeline
Published: Mar 9, 2021 | Tags: Roche, Ventana ALK (D5F3), CDx Assay, Receives, US, FDA, Approval, Treatment, ALK-Positive NSCLC
Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US
Published: Mar 9, 2021 | Tags: Abbott, Launches, NeuroSphere Virtual Clinic, Remote, Neurostim Programming, US
Published: Mar 9, 2021 | Tags: TrinamiX, Signs, Joint Development Agreement, VIAVI Solutions, Bring, Near-Infrared Spectroscopy, Smartphones
Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes
Published: Mar 9, 2021 | Tags: Lilly, Collaborates, Biolojic, Discover, Develop, Antibody, Therapies, Diabetes
Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea
Published: Mar 9, 2021 | Tags: Alteogen, Reports, Completion, P-I Study, ALT-L9 (biosimilar, aflibercept), Korea
Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI
Published: Mar 8, 2021 | Tags: Atea, Presents, Results, AT-527, P-I Study, COVID 19
Kite’s Yescarta Receives the US FDA’s Approval for R/R Follicular Lymphoma
Published: Mar 8, 2021 | Tags: Kite, Yescarta, Receives, US, FDA, Approval, R/R Follicular Lymphoma
Gilead Presents Four-Year Data of Biktarvy for HIV-1 in Treatment-Naïve Adults at CROI 2021
Published: Mar 8, 2021 | Tags: Gilead, Presents, Four-Year Data, Biktarvy, HIV-1, Treatment, Naïve Adults
Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US
Published: Mar 8, 2021 | Tags: Roche, Withdraw, Tecentriq, Indication, Metastatic, Bladder Cancer US
Published: Mar 8, 2021 | Tags: Lee’s Pharma, Initiate, P-III Trial, Socazolimab, 1L, Treatment, Extensive-stage Small-Cell Lung Cancer
Published: Mar 8, 2021 | Tags: ViiV Healthcare, Present, Results, Long- Acting, Cabotegravir, Rilpivirine, P-IIIb ATLAS-2M, Study, HIV
Related Post: PharmaShots Weekly Snapshots (Mar 01 – 05, 2021)
The post PharmaShots Weekly Snapshots (Mar 08 – 12, 2021) first appeared on PharmaShots.